SEVEN EIGHT CAPITAL, LP - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 1.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEVEN EIGHT CAPITAL, LP ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q2 2020$331,000
-86.1%
2,700
-88.1%
0.24%
+92.1%
Q4 2019$2,379,000
+1049.3%
22,751
+971.1%
0.13%
+950.0%
Q4 2018$207,000
-93.9%
2,124
-89.2%
0.01%
-94.2%
Q3 2018$3,390,000
+663.5%
19,624
+343.6%
0.21%
+221.9%
Q2 2017$444,000
+226.5%
4,424
+293.6%
0.06%
+146.2%
Q1 2017$136,000
-90.1%
1,124
-89.1%
0.03%
-93.5%
Q3 2016$1,367,000
+897.8%
10,300
+442.1%
0.40%
+587.9%
Q1 2016$137,000
+226.2%
1,900
+216.7%
0.06%
+100.0%
Q4 2015$42,000
+55.6%
600
+100.0%
0.03%
+26.1%
Q3 2015$27,000
-84.3%
300
-81.2%
0.02%
-86.1%
Q2 2014$172,0001,6000.17%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2020
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders